Nano cancer therapy strategies

Journal of Cancer Research and Therapeutics

Volumn 8, Issue 1, 2012, Pages 19-22

  Tiwari, Manjul ^a  

^a SHARDA UNIVERSITY   (India)

Author keywords

cancer therapy; drug delivery; metastatic cancer; Nanoparticle

Indexed keywords

CAMPTOTHECIN; DEXTRAN; LIPOSOME; NANOPARTICLE; PACLITAXEL; PACLITAXEL POLIGLUMEX; POLYMER;

DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; DRUG SCREENING; HUMAN; MICELLE; MOLECULARLY TARGETED THERAPY; NANOMEDICINE; REVIEW;

CLINICAL TRIALS AS TOPIC; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS;

EID: 84860489032     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.95168     Document Type: Review

References (35)

1. Frank A, Pridgen EM, Langer R, Farokhzad OC. Nanoparticle Technologies for Cancer Therapy. Drug Deliv 2010;6:55-86.
2. Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009;3:16-20.
3. Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: Bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 2006;5:1909-17. (Pubitemid 44336561)
4. Uchegbu IF. Pharmaceutical nanotechnology: Polymeric vesicles for drug and gene delivery. Expert Opin Drug Deliv 2006;3:629-40. (Pubitemid 44383490)
5. Fox JL. Researchers discuss NIH's nanotechnology initiative. Nat Biotechnol 2007;18:821.
6. Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urol Oncol 2008c;26:74-85.
7. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov 2009;7:771-82.
8. Euliss LE, DuPont JA, Gratton S, DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem Soc Rev 2006;35:1095-104. (Pubitemid 44611722)
9. Farokhzad OC. Nanotechnology for drug delivery: The perfect partnership. Expert Opin Drug Deliv 2008;5:927-9.
10. Kawasaki ES, Player A. Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomedicine 2005;1:101-9. (Pubitemid 43963616)
11. Pridgen EM, Langer R, Farokhzad OC. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine (Lond) 2007;2:669-80. (Pubitemid 350268246)
12. Ferrari M. Cancer Nanotechnology: Opportunities and Challenges. Nat Rev Cancer 2005;5:161-71.
13. Salvador-Morales C, Gao W, Ghatalia P, Murshed F, Aizu W, Langer R, et al. Multifunctional nanoparticles for prostate cancer therapy. Expert Rev Anticancer Ther 2009a;9:211-21.
14. Langer R. Drug delivery and targeting. Nature 2008;392:5-10.
15. Moghimi SM. Recent developments in polymeric nanoparticle engineering and their applications in experimental and clinical oncology. Anticancer Agents Med Chem 2006;6:553-61.
16. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004;56:1649-59. (Pubitemid 39177694)
17. Dhar S, Gu FX, Langer R, Farokhzad OC, Lippard SJ. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A 2008;105:17356-61.
18. Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R. Nanoparticle-aptamer bioconjugates: A new approach for targeting prostate cancer cells. Cancer Res 2004;64:7668-72. (Pubitemid 39446893)
19. Bagalkot V, Farokhzad OC, Langer R, Jon S. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl 2006;45:8149-52. (Pubitemid 44974149)
20. Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A 2006a;103:6315-20.
21. Farokhzad OC, Karp JM, Langer R. Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opin Drug Deliv 2006c;3:311-24. (Pubitemid 43772708)
22. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000;41:147-62. (Pubitemid 30122955)
23. Schrama D, Reisfeld RA, Becker JC. Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov 2006;5:147-59.
24. Decuzzi P, Lee S, Bhushan B, Ferrari M. A theoretical model for the margination of particles within blood vessels. Ann Biomed Eng 2005;33:179-90. (Pubitemid 40509493)
25. Decuzzi P, Pasqualini R, Arap W, Ferrari M. Intravascular delivery of particulate systems: Does geometry really matteř Pharm Res 2009;26:235-43.
26. Decuzzi P, Ferrari M. Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials 2008;29:377-84. (Pubitemid 350081047)
27. Gentile F, Chiappini C, Fine D, Bhavane RC, Peluccio MS, Cheng MM, et al. The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. J Biomech 2008a;41:2312-8.
28. Gentile F, Curcio A, Indolfi C, Ferrari M, Decuzzi P. The margination propensity of spherical particles for vascular targeting in the microcirculation. J Nanobiotechnol 2008b;6:9-11.
29. Decuzzi P, Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 2008;27:5307-14.
30. Decuzzi P, Gentile F, Granaldi A, Curcio A, Causa F, Indolfi C, et al. Flow chamber analysis of size effects in the adhesion of spherical particles. Int J Nanomed 2007;2:689-96.
31. Salvador-Morales C, Zhang L, Langer R, Farokhzad OC. Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups. Biomaterials 2009b;30:2231-40.
32. Cedervall T, Lynch I, Foy M, Berggard T, Donnelly SC, Cagney G, et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl 2007a;46:5754-6. (Pubitemid 47172204)
33. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A 2007b;104:2050-5. (Pubitemid 46391350)
34. Siclari VA, Guise TA, Chirgwin JM. Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev 2006;25:621-33. (Pubitemid 46075000)
35. Zetter BR. The scientific contributions of M. Judah Folkman to cancer research. Nat Rev Cancer 2008;8:647-54.